X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4944) 4944
Publication (406) 406
Book / eBook (108) 108
Book Chapter (96) 96
Book Review (53) 53
Web Resource (16) 16
Dissertation (13) 13
Journal / eJournal (9) 9
Conference Proceeding (7) 7
Magazine Article (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3108) 3108
hematological malignancies (2587) 2587
index medicus (2319) 2319
hematology (1830) 1830
male (1772) 1772
female (1759) 1759
oncology (1498) 1498
middle aged (1418) 1418
adult (1362) 1362
cancer (1221) 1221
aged (1107) 1107
leukemia (896) 896
adolescent (750) 750
hematological malignancy (715) 715
transplantation (606) 606
chemotherapy (575) 575
risk factors (515) 515
child (504) 504
acute myeloid-leukemia (501) 501
care and treatment (470) 470
aged, 80 and over (469) 469
retrospective studies (466) 466
young adult (453) 453
treatment outcome (445) 445
research (424) 424
analysis (421) 421
immunology (408) 408
health aspects (401) 401
lymphoma (392) 392
diagnosis (391) 391
stem cells (382) 382
haematological malignancy (368) 368
prognosis (368) 368
animals (360) 360
child, preschool (358) 358
haematological malignancies (358) 358
infectious diseases (357) 357
mortality (351) 351
medicine & public health (348) 348
acute lymphoblastic-leukemia (345) 345
lymphomas (333) 333
epidemiology (318) 318
bone-marrow-transplantation (308) 308
therapy (300) 300
patients (299) 299
hematopoietic stem cells (294) 294
medicine (287) 287
children (281) 281
stem-cell transplantation (278) 278
hematologic neoplasms - complications (273) 273
hematologic neoplasms - therapy (265) 265
neutropenia (265) 265
chronic lymphocytic-leukemia (260) 260
survival (260) 260
pharmacology & pharmacy (252) 252
microbiology (249) 249
medicine, general & internal (243) 243
cancer-patients (239) 239
infant (236) 236
tumors (235) 235
prospective studies (233) 233
apoptosis (228) 228
blood (228) 228
hematopoietic stem cell transplantation (225) 225
multiple-myeloma (224) 224
medical research (222) 222
incidence (221) 221
hematologic neoplasms - drug therapy (220) 220
multiple myeloma (214) 214
risk-factors (214) 214
bone marrow (212) 212
cell biology (201) 201
diseases (201) 201
risk (200) 200
infections (195) 195
disease (193) 193
antifungal agents - therapeutic use (192) 192
infection (192) 192
mutation (192) 192
research article (187) 187
immunotherapy (186) 186
antineoplastic agents - therapeutic use (182) 182
hematological diseases (179) 179
hematology, oncology and palliative medicine (174) 174
pediatrics (174) 174
hematopoietic stem cell transplantation - adverse effects (169) 169
hemic and lymphatic diseases (169) 169
medicine, experimental (169) 169
genetic aspects (168) 168
versus-host-disease (168) 168
aspergillosis (167) 167
review (166) 166
stem cell transplantation (166) 166
fungal-infections (165) 165
neutropenic patients (164) 164
transplantation, homologous (162) 162
management (158) 158
internal medicine (155) 155
survival analysis (155) 155
acute myeloid leukemia (153) 153
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (56) 56
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (18) 18
Online Resources - Online (12) 12
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Gerstein Science - Periodical Stacks (2) 2
Markham Stouffville Hospital - Stacks (2) 2
Scarborough Hospital - General (2) 2
St. Michael's Hospital - Stacks (2) 2
Toronto East General Hospital - Stacks (2) 2
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Online (1) 1
Mt Sinai Hospital - Online (1) 1
New College (Ivey) - Stacks (1) 1
St Josephs Health Centre - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Women's College Hospital - Online (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4884) 4884
French (65) 65
Russian (63) 63
Japanese (56) 56
Spanish (47) 47
German (28) 28
Polish (20) 20
Czech (10) 10
Chinese (8) 8
Turkish (7) 7
Hungarian (6) 6
Italian (5) 5
Portuguese (4) 4
Korean (3) 3
Arabic (2) 2
Persian (2) 2
Dutch (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2012, Radiation medicine rounds, ISBN 9781936287772, Volume 3, issue 3
Book
Current hematologic malignancy reports, ISSN 1558-8211, 2006
Journal
Reviews in clinical and experimental hematology, ISSN 1127-0020, 1997
Journal
2011, 1, ISBN 9780521896405, vii, 517
"Hematologic malignancies were the first human cancers to be studied in depth at the molecular level, and recent years have seen important advances in... 
diagnosis | Lymphoproliferative disorders | Treatment | Hematologic Neoplasms | therapy | Clinical & internal medicine | Hematological oncology | Lymphomas
Book
2008, Cancer treatment and research, ISBN 9780387737447, Volume 142., x, 432
Every practicing hematologist/oncologist or primary care physician intermittently encounters patients with uncommon or rare hematologic malignancies.... 
Hematological oncology | Oncology | Medicine & Public Health | Hematology
Book
2013, 5th ed., ISBN 9781461437635, xix, 1431
Neoplastic Diseases of the Blood integrates the history, epidemiology, pathology, pathophysiology, and therapeutics of modern neoplastic hematopathology. The... 
Hematologic Neoplasms | Lymphoma | Leukemia | Multiple Myeloma | Clinical & internal medicine | Blood | Lymphomas | Multiple myeloma | Oncology | Internal Medicine | Medicine & Public Health | Hematology | Hematological oncology
Book
Journal Article
2003, Methods in Molecular Biology, ISBN 9781588290809, Volume 220, xi, 283
Cytogenetic studies of malignancy have become an essential tool in the clinical management of cancer patients, but they are not uniformly utilized, even in... 
Laboratory manuals | Genetic aspects | Cancer | Human genetics | Human Genetics | Biomedicine
Book
Febrile neutropenia in haematological malignancies, 12/2005
Fever is the principle sign of infection in neutropenic patient and frequently may be the only evidence of infection. The pattern of fever in neutropenia is... 
Febrile neutropenia, Liposomal Amphotericin B, Fever, Haematological malignancies
Journal
2007, 2nd ed., Contemporary hematology, ISBN 9781588295576, xi, 498
Now in its second edition Modern Hematology reflects the major advances in the understanding, diagnosis, and treatment of blood disorders. Each chapter is... 
Hematologic Diseases | Hematology | Hematologic Neoplasms | Blood | Diseases | Clinical & internal medicine | Medicine & Public Health
Book
2003, Palliative care consultations, ISBN 9780198528081, xii, 254
This book is the first volume in an international, multi-contributed series aimed at providing practical, clinical guidance on how to deal with difficult... 
Palliative Care | Hematologic Neoplasms | therapy | methods | palliative medicine
Book
Oncogene, ISSN 0950-9232, 05/2013, Volume 32, Issue 21, pp. 2601 - 2613
The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is central to signaling by cytokine receptors, a superfamily of more... 
hematological malignancies | leukemia | JAK/STAT | COLONY-STIMULATING FACTOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | ERYTHROPOIETIN RECEPTOR ACTIVATION | ACUTE MYELOID-LEUKEMIA | PROTEIN-TYROSINE KINASE | OF-FUNCTION MUTATIONS | CELL BIOLOGY | ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | HEMATOPOIETIC STEM-CELLS | GENETICS & HEREDITY | ACUTE MEGAKARYOBLASTIC LEUKEMIA | ACQUIRED UNIPARENTAL DISOMY | CLASSICAL HODGKIN LYMPHOMA | Gene Expression Regulation, Enzymologic - drug effects | Janus Kinase 2 - biosynthesis | Hodgkin Disease - genetics | Humans | STAT Transcription Factors - metabolism | Mutation, Missense | Neoplasm Proteins - metabolism | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Hodgkin Disease - drug therapy | Gene Expression Regulation, Neoplastic - drug effects | Neoplasm Proteins - genetics | Gene Expression Regulation, Neoplastic - genetics | Hematologic Neoplasms - metabolism | Janus Kinase 2 - antagonists & inhibitors | Hodgkin Disease - metabolism | Signal Transduction | Janus Kinase 2 - genetics | Exons - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | STAT Transcription Factors - genetics | Animals | Gene Expression Regulation, Enzymologic - genetics | Protein Kinase Inhibitors - therapeutic use | Hematologic Neoplasms - drug therapy | Hematologic Neoplasms - genetics | Amino Acid Substitution | Physiological aspects | Lymphomas | Research | Leukemia | Analysis | STAT proteins | Signal transduction | Gene expression | Multiple myeloma
Journal Article
2006, Best practice & research. Clinical haematology, Volume 19, no. 4., 635-847
Book
2010, 1st Edition., Contemporary hematology, ISBN 1588299864, x, 371
In this book, the authors and editor draw on their extensive expertise to provide a roadmap for hematologists to efficiently manage the complex infections... 
Infection | Hematologic Neoplasms | complications | therapy | methods | Infection Control | Clinical & internal medicine | Hematologic Neoplasms - complications | Medicine & Public Health | Hematology | Oncology
Book
1998, Basic and clinical oncology, ISBN 9780824798864, Volume 14., ix, 572
Book
1999, ISBN 1853173223, xvi, 944
Book
Immunology, ISSN 0019-2805, 11/2017, Volume 152, Issue 3, pp. 357 - 371
Summary The introduction of PD‐1/PD‐L1 pathway inhibitors is an important landmark in solid oncology with unprecedented practice‐changing activity in various... 
pembrolizumab | myeloma | programmed death 1 receptor | haematological malignancy | nivolumab | MULTIPLE-MYELOMA | PROGNOSTIC-FACTORS | DEATH-LIGAND 1 | BRENTUXIMAB VEDOTIN | FOLLICULAR LYMPHOMA | IMMUNOLOGY | IMMUNE CHECKPOINT | CLASSICAL HODGKIN LYMPHOMA | STEM-CELL TRANSPLANTATION | T-CELLS | PD-1 EXPRESSION | Humans | Programmed Cell Death 1 Receptor - metabolism | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Treatment Outcome | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Hematologic Neoplasms - pathology | Evidence-Based Medicine | Molecular Targeted Therapy | B7-H1 Antigen - immunology | B7-H1 Antigen - metabolism | Animals | B7-H1 Antigen - antagonists & inhibitors | Signal Transduction - drug effects | Antineoplastic Agents - adverse effects | Hematologic Neoplasms - drug therapy | Hematologic Neoplasms - immunology | Programmed Cell Death 1 Receptor - immunology | Hematologic Neoplasms - metabolism | Monoclonal antibodies | Non-Hodgkin's lymphomas | T cells | Drug approval | Multiple myeloma | Cancer | Corticoids | Drugs | Chronic lymphatic leukemia | Corticosteroids | Hematology | PD-1 protein | Toxicity | Immunomodulation | Leukemia | Lymphocytes T | Lymphoma | Myelodysplastic syndrome | Overexpression | Inhibitors | Lymphocytes B | Chromosome 9 | PD-L1 protein | Lymphomas | Hodgkin's disease | Tumors | B-cell lymphoma | Index Medicus | Review
Journal Article